Breaking Biotech

Matthew Lepoire

Matt goes in-depth on various biotechnology companies to find good quality trading opportunities.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Breaking Biotech" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Breaking Biotech

Episodes (10)

May 8, 2022 113 - Vaxxinity Takes on Neurodegenerative Diseases with Vaccines - Potential Short Opportunity?
Apr 21, 2022 112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
Apr 1, 2022 111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich

Breaking Biotech

May 8, 2022
46½ minutes
104 MB

Video Sponsor - http://workinbiotech.com/ In this episode, I go through a company called Vaxxinity, who are trying to develop vaccines for the treatment of various different diseases. They have a novel vaccine platform whereby they hope to induce both a humoral and T-cell response to specific proteins in various indications. One of their near-term readouts is a Phase 1 Part 2 data release from their UB-312 program in Parkinson Disease. This treatment is able to induce anti-α-synuclein antibodies, but I compare their data to two other programs that are further along to explain why they might n...

Breaking Biotech

113 - Vaxxinity Takes on Neurodegenerative Diseases with Vaccines - Potential Short Opportunity?

Matthew Lepoire

00:00 -45:36